Drug Type Antibody drug conjugate (ADC) |
Synonyms izeltabart tapatansine, 他坦伊妥拜单抗 |
Target |
Mechanism ADAM9 inhibitors(ADAM metallopeptidase domain 9 inhibitors), Tubulin inhibitors |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H27N5O6 |
InChIKeyGIFCVLHWAKOETA-RYUDHWBXSA-N |
CAS Registry- |